Guerbet (FR0000032526 GBT), a global leader in medical imaging, announced that the U.S. Food and Drug Administration (FDA) after priority review, approved Elucirem (Gadopiclenol),...
Guerbet, a global leader in medical imaging offering a comprehensive range of pharmaceutical products, medical devices, and digital and artificial intelligence (AI) solutions for...
